Creso Pharma (ASX:CPH) shares up 30pc amid speculation on U.S. cannabis bill, page-1350

Agree, however I don't think there are quite that mamy companies in a strong position, maybe a couple of dozen companies, but not hundreds. Again, i agree with your point that the dilution does certainly make reaching those highs from the past difficult, but not impossible. So much will come down to our ability to execute when/if the time comes to do so. Alot will hinge on management and their business acumen. I'm a believer, and good luck to all holders. Just my opinion.